68 related articles for article (PubMed ID: 18957280)
21. FoxO3a is an antimelanogenic factor that mediates antioxidant-induced depigmentation.
Kim J; Choi H; Cho EG; Lee TR
J Invest Dermatol; 2014 May; 134(5):1378-1388. PubMed ID: 24284420
[TBL] [Abstract][Full Text] [Related]
22. Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a.
You H; Yamamoto K; Mak TW
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9051-6. PubMed ID: 16757565
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of wild-type p66ShcA in mesangial cells prevents glycooxidant-dependent FOXO3a regulation and promotes the survival phenotype.
Chintapalli J; Yang S; Opawumi D; Goyal SR; Shamsuddin N; Malhotra A; Reiss K; Meggs LG
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F523-30. PubMed ID: 17077388
[TBL] [Abstract][Full Text] [Related]
24. Cell proliferation is a key determinant of the outcome of FOXO3a activation.
Poulsen RC; Carr AJ; Hulley PA
Biochem Biophys Res Commun; 2015 Jun; 462(1):78-84. PubMed ID: 25935481
[TBL] [Abstract][Full Text] [Related]
25. Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation.
Polter A; Yang S; Zmijewska AA; van Groen T; Paik JH; Depinho RA; Peng SL; Jope RS; Li X
Biol Psychiatry; 2009 Jan; 65(2):150-9. PubMed ID: 18823877
[TBL] [Abstract][Full Text] [Related]
26. Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression.
Hasegawa K; Wakino S; Yoshioka K; Tatematsu S; Hara Y; Minakuchi H; Washida N; Tokuyama H; Hayashi K; Itoh H
Biochem Biophys Res Commun; 2008 Jul; 372(1):51-6. PubMed ID: 18485895
[TBL] [Abstract][Full Text] [Related]
27. Low-dose dexamethasone promotes osteoblast viability by activating autophagy via the SGK1/FOXO3a signaling pathway.
Yu XH; Xu XM; Zhang SX
Cell Biol Int; 2023 Mar; 47(3):669-678. PubMed ID: 36453461
[TBL] [Abstract][Full Text] [Related]
28. Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis.
van Grevenynghe J; Cubas RA; Noto A; DaFonseca S; He Z; Peretz Y; Filali-Mouhim A; Dupuy FP; Procopio FA; Chomont N; Balderas RS; Said EA; Boulassel MR; Tremblay CL; Routy JP; Sékaly RP; Haddad EK
J Clin Invest; 2011 Oct; 121(10):3877-88. PubMed ID: 21926463
[TBL] [Abstract][Full Text] [Related]
29. FOXO3a functions as a transcriptional and co-transcriptional splicing regulator in vascular endothelial cell lines.
Abudureyimu S; He C; Xie W; Chen Z; Airikenjiang H; Abulaiti D; Cao Y; Qiu H; Gao Y
Gene; 2024 Apr; 904():148221. PubMed ID: 38286271
[TBL] [Abstract][Full Text] [Related]
30. FOXO3a in cancer drug resistance.
Liu Y; Wang Y; Li X; Jia Y; Wang J; Ao X
Cancer Lett; 2022 Aug; 540():215724. PubMed ID: 35545128
[TBL] [Abstract][Full Text] [Related]
31. Enhanced expression of adipocyte-type fatty acid binding protein in murine lymphocytes in response to dexamethasone treatment.
Abdelwahab SA; Owada Y; Kitanaka N; Adida A; Sakagami H; Ono M; Watanabe M; Spener F; Kondo H
Mol Cell Biochem; 2007 May; 299(1-2):99-107. PubMed ID: 17111194
[TBL] [Abstract][Full Text] [Related]
32. Potent FOXO3a Activators from Biologically Active Compound Library for Cancer Therapeutics: An in silico Approach.
Manoharan S; Vedagiri H; Perumal E
Appl Biochem Biotechnol; 2023 Aug; 195(8):4995-5018. PubMed ID: 37017892
[TBL] [Abstract][Full Text] [Related]
33. Casticin induces breast cancer cell apoptosis by inhibiting the expression of forkhead box protein M1.
Liu LP; Cao XC; Liu F; Quan MF; Sheng XF; Ren KQ
Oncol Lett; 2014 May; 7(5):1711-1717. PubMed ID: 24765206
[TBL] [Abstract][Full Text] [Related]
34. A missense mutation in the transcription factor Foxo3a causes teratomas and oocyte abnormalities in mice.
Youngson NA; Vickaryous N; van der Horst A; Epp T; Harten S; Fleming JS; Khanna KK; de Kretser DM; Whitelaw E
Mamm Genome; 2011 Apr; 22(3-4):235-48. PubMed ID: 21347845
[TBL] [Abstract][Full Text] [Related]
35. Remarkably reduced expression of FoxO3a in metaplastic colorectum, primary colorectal cancer and liver metastasis.
He LY; Wei X; Du L; Liu L; Xu F; Min J; Li C; Tao DD; Chen Q; Hu JB; Gong JP
J Huazhong Univ Sci Technolog Med Sci; 2013 Apr; 33(2):205-211. PubMed ID: 23592131
[TBL] [Abstract][Full Text] [Related]
36. Gene expression profile of human lymphoid CEM cells sensitive and resistant to glucocorticoid-evoked apoptosis.
Medh RD; Webb MS; Miller AL; Johnson BH; Fofanov Y; Li T; Wood TG; Luxon BA; Thompson EB
Genomics; 2003 Jun; 81(6):543-55. PubMed ID: 12782123
[TBL] [Abstract][Full Text] [Related]
37. Comment on "Transcription factor FOXO3a mediates apoptosis in HIV-1-infected macrophages".
Noursadeghi M; Tsang J; Miller RF; Katz DR
J Immunol; 2008 Jun; 180(12):7783; author reply 7783-4. PubMed ID: 18523241
[No Abstract] [Full Text] [Related]
38. FOXO3a: A Potential Target in Prostate Cancer.
Shukla S
Austin J Urol; 2014; 1(1):. PubMed ID: 25584362
[No Abstract] [Full Text] [Related]
39. Beyond Corticoresistance, A Paradoxical Corticosensitivity Induced by Corticosteroid Therapy in Pediatric Acute Lymphoblastic Leukemias.
Angot L; Schneider P; Vannier JP; Abdoul-Azize S
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345151
[TBL] [Abstract][Full Text] [Related]
40. Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities.
Nova Z; Zemanek T; Botek N
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
